Synthetic chemistry’s dependence on manual reiteration and expertise has been a barrier to planning and building active pharmaceutical ingredients. Computer-assisted retrosynthesis technologies that are supported by AI are revolutionizing route design for therapeutic synthesis, enabling safer, more sustainable, and green-by-design active pharmaceutical ingredients.
Download this Research Product Blog to explore how new computational tools leverage multi-target retrosynthesis and machine learning to build better synthetic chemistry routes.
